Search
Feed aggregator
FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format
FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format 5/7/2024
FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info
FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info 6/28/2024
Alumis Pushes Through With Smaller IPO, Looks to Raise $250M for Immuno Candidate
Alumis Pushes Through With Smaller IPO, Looks to Raise $250M for Immuno Candidate 6/28/2024
ICER Doubles Down on Critique of Lykos’ MDMA Therapy, Cites Data Concerns
ICER Doubles Down on Critique of Lykos’ MDMA Therapy, Cites Data Concerns 6/28/2024
FDA Needs to Step Up As Use of Third-Party Manufacturers Leads to Rejections
FDA Needs to Step Up As Use of Third-Party Manufacturers Leads to Rejections 6/28/2024
With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients
With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients 6/28/2024
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff 6/28/2024
AbbVie Expands Immuno Portfolio With $250M Celsius Buy as Humira Hits Patent Cliff
AbbVie Expands Immuno Portfolio With $250M Celsius Buy as Humira Hits Patent Cliff 6/28/2024
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection 6/27/2024
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout 6/27/2024
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss 6/27/2024
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma 6/27/2024
CDC Narrows RSV Vaccine Recommendations for Seniors
CDC Narrows RSV Vaccine Recommendations for Seniors 6/27/2024
New Team, Same Company: How to Transition to Your New Role
New Team, Same Company: How to Transition to Your New Role 6/27/2024
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search 6/27/2024
5 Top Companies Hiring in the Washington, D.C., Area
5 Top Companies Hiring in the Washington, D.C., Area 6/27/2024
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate 6/26/2024
Zealand to Raise $1B in Public Offering to Fund Obesity Candidates
Zealand to Raise $1B in Public Offering to Fund Obesity Candidates 6/26/2024
Curie.Bio Adds $380M Series A Fund to Move Biotech Startups to Clinic
Curie.Bio Adds $380M Series A Fund to Move Biotech Startups to Clinic 6/26/2024
Lilly Teams With OpenAI to Tackle Threat of Drug-Resistant Bacteria
Lilly Teams With OpenAI to Tackle Threat of Drug-Resistant Bacteria 6/26/2024
World Pharma News
- Innovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer
- Sanofi announces the signing of a share buyback mandate for up to €1 billion
- How a heart medication could unlock a new targeted approach in lymphoma
- A broken DNA repair tool accelerates aging
- AstraZeneca begins trading on the New York Stock Exchange